Showing 2 posts of 2 posts found.


NHS to utilise first-ever cannabis-based therapies following NICE recommendation of two GW Pharma drugs

November 11, 2019
Sales and Marketing Epidyolex, GW Pharma, NHS, Sativex, pharma

The NHS is authorised to use its first two cannabis-based medicines for routine use after NICE saw fit to recommend …


NICE refuses GW Pharma’s cannabis-based Epidyolex for treatment-resistant epilepsy

August 27, 2019
Manufacturing and Production, Sales and Marketing Epidiolex, Epidyolex, GW Pharma, NICE, cannabidiol, cannabis, pharma

UK-based GW Pharma has suffered a setback in its home country after drug watchdog NICE chose not to recommend NHS …

Latest content